Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Audientes A/S Logo
Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.
Denmark
AUDNTS
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America
AMIX
AVANOS MEDICAL, INC. Logo
Medical devices for non-opioid pain management and chronic care enteral feeding solutions.
United States of America
AVNS
AVITA Medical, Inc. Logo
Regenerative solutions for burns and wounds using a patient's own Spray-On Skin™ Cells.
United States of America
RCEL
Bactiguard Holding Logo
Licenses a patented coating to MedTech partners to prevent medical device infections.
Sweden
BACTI
Beauty Health Co Logo
Develops aesthetic tech and skin treatments like Hydrafacial for professionals and consumers.
United States of America
SKIN
BECTON DICKINSON & CO Logo
Develops medical supplies, devices & diagnostics for healthcare and life science researchers.
United States of America
BDX
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom
BELL
Beyond Air, Inc. Logo
Develops on-demand nitric oxide generators from air for hospital respiratory treatments.
United States of America
XAIR
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden
BIBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.